Detail Data
Volume (24h): 691,418 shares
P/E Ratio: 31.76
Forward P/E: 22.64
EPS: 4.17 USD
Forward EPS: 5.85 USD
Number of Shares: 28,898,700 shares
Market Capitalization: 3,827,921,920.00 USD

Dividend

Dividend Value
Dividend Amount According to our data, the company Krystal Biotech does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a none recommendation for Krystal Biotech stock. The current number of analysts covering this company is 10. The highest target price is 245 USD, while the lowest target price is 155 USD. The median target valuation set by analysts is 201 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Krystal Biotech.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Krystal Biotech stock is: none
Number of Analysts: 10
Highest Target Price: 245 USD
Lowest Target Price: 155 USD
Median Target Price: 201 USD

Fundamental Indicators

Indicator Data
Total Revenue: 333,448,000.00 USD
Net Income: 123,960,000.00 USD
Price-to-Book (P/B): 3.89
PEG Ratio: /
Exchange: NasdaqGS
Industry: Biotechnology
Sector: Healthcare
Number of Employees: 275
Country: United States

Where to Buy Krystal Biotech Stock?

You can purchase Krystal Biotech stock on the NasdaqGS under the ticker symbol: KRYS. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Krystal Biotech Stock

Indicator Value
Company Revenue: 333,448,000.00 USD
EBITDA: 135,908,000.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share: 4.17 USD
Book Value Per Share: 34.07 USD
Total Cash: 616,846,016.00 USD
Total Cash per Share: 21.35 USD
Total Debt: 9,662,000.00 USD
Debt to Equity Ratio: 0.01
Quick Ratio 9.06
Current Ratio 9.65
Free Cash Flow 76,742,496.00 USD
Operating Cash Flow 138,500,992.00 USD
Gross Margins 93.20 %
EBITDA Margins 40.76 %
Operating Margins 41.03 %
Profit Margins 37.18 %
Return on Assets 8.7 %
Return on Equity 13.9 %
Earnings Growth (1 year) 3,900.0%
Revenue Growth (1 year) 94.9 %
Quarterly Earnings Year-over-Year Growth 3,734.0 %
Market Capitalization 3,827,921,920.00 USD
Enterprise Value 3,220,735,232.00 USD
EV/Revenue 9.659
EV/EBITDA 23.698
Float Shares 22,814,352 shares
Shares Outstanding 28,898,700 shares
Held Percent Insiders 0.12 %
Held Percent Institutions 104.11 %
Shares Short 2,921,085
Shares Short Prior Month 2,367,240
Date Short Interest 2025-05-30
Short Percentage of Total Shares 10.11 %
Short Ratio 6.99
Beta 0.66
Short Percentage of Float 16.96 %
Implied Shares Outstanding 28,898,700

Frequently Asked Questions (FAQ)

According to our data, the company Krystal Biotech does not pay dividends yet, even in 2025.

Krystal Biotech shares are traded on the NasdaqGS stock exchange under the ticker: KRYS. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for Krystal Biotech shares is from a total of 10 analysts. The average target price prediction is 201 USD per share.

The total number of Krystal Biotech shares on the exchange is 28,898,700.00 shares, which at the current market capitalization gives the company a total valuation of 3,827,921,920.00 USD.